Saturday, 1 October, 2022
HomeIndiaCBI books Amrapali Biotech over alleged fraud of Rs 47.97 crore in...

CBI books Amrapali Biotech over alleged fraud of Rs 47.97 crore in PNB

CBI also booked the company's directors for misappropriating the loan amount given to them by the bank 'with an ulterior motive to embezzle the public money'.

Text Size:

New Delhi: The CBI has filed an FIR against Amrapali Biotech and its directors over alleged fraud to the tune of Rs 47.97 crore in Punjab National Bank, officials said Friday.

The agency has also booked Sunil Kumar, Sudhir Kumar Chaudhary, Ram Vivek Singh, Seema Kumari, Sunita Kumari on a complaint from Punjab National Bank, they said.

The bank concerned was originally Oriental Bank of Commerce which merged in Punjab National Bank with effect from April 1, 2020.

“It was alleged that said private company and its Directors had misappropriated the loan amount of Rs. 47.97 crore (approximately), which was sanctioned & disbursed for setting up units for manufacturing of food products like jam, sauce, pickles, cornflakes etc. in Rajgir District- Nalanda & Navanagar, District Buxar (Bihar), with an ulterior motive to cheat the bank and embezzle the public money,” CBI Spokesperson RC Joshi said.

He said an alleged loss to the tune of Rs. 35.25 crore (approx.), apart from interest on loan amount, was caused to the bank which is due from the date it was declared Non Performing Asset on July 1, 2016.

“Searches were conducted at the premises of the accused which led to recovery of some incriminating documents,” he said.

Also read: Former CBI special director Rakesh Asthana takes charge as Delhi Police Commissioner


Subscribe to our channels on YouTube & Telegram

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

Most Popular